Walpar Nutritions Limited

WALPAR NSE Healthcare Pharmaceuticals
₹115.10
+4.97%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.89.
  • Comfortable interest cover: operating profit covers interest about 8.3 times.
  • Return on equity is moderate at 13.9%.
  • Return on capital employed is moderate at 14.8%.
  • Profit has compounded about 75% a year over five years.
  • Sales have compounded about 67% a year over five years.
  • Promoters hold a majority stake (68.82%).

!Watch-points

  • Net profit margin is slim at 3.8%.
  • Recent profit growth (6%) is slower than the five-year pace (75%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
1.92

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
3 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 105 Cr
Current Price₹ 115.10
High / Low₹ 50.60 / 21.25
Stock P/E104.63636
Book Value₹ 20.10
Dividend Yield0%
ROCE14.80%
ROE13.90%
Face Value₹ 10.00
Debt to Equity0.89
PEG Ratio0.14
EV / EBITDA4.35
Industry PE35.70
P/B Ratio6.084474
EPS₹ 2.63
Debt₹ 17 Cr
PAT Margin3.81%
Cash PAT₹ 5 Cr
ICR8.32
Promoter Holding68.82%
FII Holding
DII Holding
Public Holding31.18%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 67.00%
3 Years 31.00%
TTM 10.00%
Compounded Profit Growth
10 Years
5 Years 75.00%
3 Years 61.00%
TTM 6.00%
Stock Price CAGR
10 Years
5 Years 3.00%
3 Years -20.00%
1 Year -45.00%
Return on Equity
10 Years
5 Years 11.00%
3 Years 14.00%
Last Year 14.00%
Educational data only. Not a recommendation to buy, sell or hold any security.